Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients
暂无分享,去创建一个
D. Solomon | K. Garg | J. Rabban | C. Zaloudek | N. Joseph | N. Frizzell
[1] B. Clarke,et al. Current Morphologic Criteria Perform Poorly in Identifying Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-associated Uterine Leiomyomas , 2014, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[2] B. Bastian,et al. CNVkit: Copy number detection and visualization for targeted sequencing using off-target reads , 2014, bioRxiv.
[3] E. Oliva,et al. Uterine Leiomyomas With Bizarre Nuclei: A Clinicopathologic Study of 59 Cases , 2014, The American journal of surgical pathology.
[4] M. Berger,et al. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer: Recognition of the Syndrome by Pathologic Features and the Utility of Detecting Aberrant Succination by Immunohistochemistry , 2014, The American journal of surgical pathology.
[5] V. Reuter,et al. Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC): A Rapid Autopsy Report of Metastatic Renal Cell Carcinoma , 2014, The American journal of surgical pathology.
[6] D. Nonaka,et al. Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry , 2013, Modern Pathology.
[7] W. Linehan,et al. Morphologic and Molecular Characteristics of Uterine Leiomyomas in Hereditary Leiomyomatosis and Renal Cancer (HLRCC) Syndrome , 2013, The American journal of surgical pathology.
[8] S. Oosting,et al. Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance , 2011, Familial Cancer.
[9] L. Aaltonen,et al. Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation status , 2011, The Journal of pathology.
[10] L. Thomas,et al. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma , 2011, Journal of Medical Genetics.
[11] W. Linehan,et al. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. , 2008, Archives of dermatology.
[12] M. Merino,et al. The Morphologic Spectrum of Kidney Tumors in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) Syndrome , 2007, The American journal of surgical pathology.
[13] R. Houlston,et al. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas. , 2006, Cancer letters.
[14] J R Griffiths,et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.
[15] L. Aaltonen,et al. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. , 2004, The American journal of pathology.
[16] P. Choyke,et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. , 2003, American journal of human genetics.
[17] N P Burrows,et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. , 2003, Human molecular genetics.
[18] A. Paetau,et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.